Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Regulus Therapeutics Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −3 vs. Q2 2021
- Shares held
- 23.0M
- −101.8K (−0.4%) vs. Q2 2021
- Total value
- $15.9M
- −$2.88M (−15.4%) vs. Q2 2021
- New holders
- 6
- 8 more added
- Sold out
- 9
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RGLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $760 |
| Q1 2025 | 75 | $107.0M |
| Q4 2024 | 69 | $84.5M |
| Q3 2024 | 70 | $89.1M |
| Q2 2024 | 63 | $109.5M |
| Q1 2024 | 45 | $147.3M |
| Q4 2023 | 26 | $14.2M |
| Q3 2023 | 25 | $15.0M |
| Q2 2023 | 26 | $15.0M |
| Q1 2023 | 27 | $6.82M |
| Q4 2022 | 28 | $11.1M |
| Q3 2022 | 25 | $13.8M |
| Q2 2022 | 28 | $12.6M |
| Q1 2022 | 37 | $18.1M |
| Q4 2021 | 38 | $9.54M |
| Q3 2021 | 42 | $15.9M |
| Q2 2021 | 45 | $18.7M |
| Q1 2021 | 44 | $42.6M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Regulus Therapeutics Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 6,451,056 | $4.46M | 0.06% | 00.0% | Unchanged |
| Endurant Capital Management LP | 3,547,208 | $2.45M | 0.74% | +939,534+36.0% | Added |
| Vanguard Group Inc | 3,105,045 | $2.15M | 0.00% | +9,808+0.3% | Added |
| Victory Capital Management Inc | 2,227,212 | $1.54M | 0.00% | −10,730−0.5% | Reduced |
| Sarissa Capital Management LP | 1,851,851 | $1.28M | 0.10% | 00.0% | Unchanged |
| Asymmetry Capital Management, L.P. | 1,401,491 | $968.0K | 0.58% | −49,286−3.4% | Reduced |
| Ikarian Capital, LLC | 1,228,416 | $849.0K | 0.19% | −17,573−1.4% | Reduced |
| Geode Capital Management, LLC | 670,747 | $463.0K | 0.00% | +81,551+13.8% | Added |
| Morgan Stanley | 564,462 | $390.0K | 0.00% | +64,837+13.0% | Added |
| Bank of America Corp | 393,307 | $271.0K | 0.00% | +189,121+92.6% | Added |
| Acadian Asset Management LLC | 246,191 | $170.0K | 0.00% | −358,827−59.3% | Reduced |
| State Street Corp | 176,494 | $122.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 164,155 | $113.0K | 0.00% | +38,862+31.0% | Added |
| Boothbay Fund Management, LLC | 124,056 | $86.0K | 0.00% | −17,573−12.4% | Reduced |
| Northern Trust Corp | 117,654 | $81.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 111,000 | $76.0K | 0.00% | +31,000+38.8% | Added |
| Group One Trading, L.P. | 89,077 | $62.0K | 0.00% | −104,484−54.0% | Reduced |
| Grimes & Company, Inc. | 71,671 | $49.0K | 0.00% | +8,409+13.3% | Added |
| Gsa Capital Partners LLP | 64,708 | $45.0K | 0.00% | −141,557−68.6% | Reduced |
| Lido Advisors, LLC | 57,500 | $39.0K | 0.00% | 00.0% | Unchanged |
| GYL Financial Synergies, LLC | 41,000 | $28.0K | 0.01% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 38,100 | $26.0K | 0.00% | +38,100 | New |
| Citadel Advisors LLC | 35,357 | $24.0K | 0.00% | −244,378−87.4% | Reduced |
| Simplex Trading, LLC | 18,323 | $15.0K | 0.00% | −2,000−9.8% | Reduced |
| UBS Group AG | 19,874 | $14.0K | 0.00% | +19,874 | New |
| McGuire Investment Group, LLC | 15,000 | $10.0K | 0.00% | −9,000−37.5% | Reduced |
| Creative Planning | 14,200 | $10.0K | 0.00% | 00.0% | Unchanged |
| All Terrain Financial Advisors, LLC | 15,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 14,000 | $10.0K | 0.00% | +14,000 | New |
| Dowling & Yahnke LLC | 12,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 13,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 11,900 | $8.00K | 0.00% | +11,900 | New |
| Blair William & Co | 10,700 | $7.00K | 0.00% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 10,610 | $7.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 7,085 | $5.00K | 0.00% | −547−7.2% | Reduced |
| Royal Bank of Canada | 7,063 | $5.00K | 0.00% | 00.0% | Unchanged |
| Community Bank, N.A. | 6,900 | $5.00K | 0.00% | 00.0% | Unchanged |
| AdvisorNet Financial, Inc | 7,500 | $5.00K | 0.00% | +7,500 | New |
| BlackRock Inc. | 2,320 | $2.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Sonora Investment Management, LLC | 16 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 50 | $0 | 0.00% | +50 | New |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −91,872−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −79,193−100.0% | Sold out |
| Strategic Wealth Advisors Group, LLC | 0 | $0 | 0.00% | −74,800−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −59,432−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −37,741−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −28,346−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −22,300−100.0% | Sold out |
| Endurance Wealth Management, Inc. | 0 | $0 | 0.00% | −6,750−100.0% | Sold out |